Metastatic Gastric Cancer: Factors in Selecting Frontline Therapy

Video

Transcript:

Related Videos
Michael Iglesia, MD, PhD
Jin Qian, PhD
Michael Iglesia, MD, PhD
Kian-Huat Lim, MD, PhD
Related Content
Timothy L. Cannon, MD

Pertuzumab Plus Trastuzumab Surpasses Prespecified Activity Threshold in ERBB2/3-Altered Biliary Tract Cancer

May 15th 2024
Article
Gina Z. D’Amato, MD

D'Amato Discusses Research and Resistance Mechanisms in Sarcoma and Gastrointestinal Stromal Tumor

February 9th 2023
Podcast
Susanna Hegewisch-Becker, MD, PhD

Relatlimab Plus Nivolumab/Chemo Misses ORR End Point in LAG-3+ Advanced Gastric/GEJ Cancer

May 14th 2024
Article
Nicholas Acuna, MPH

Acuna Discusses US Liver Cancer Incidence in Individuals of Mexican Descent

December 12th 2022
Podcast
Gastric cancer | Image Credit: © Rasi - stock.adobe.com

IBI343 Receives Breakthrough Therapy Designation in China for Claudin 18.2+ Advanced Gastric/GEJ Cancer

May 8th 2024
Article
US FDA

FDA Grants Orphan Drug Designation to 9MW2821 for Esophageal Cancer

May 8th 2024
Article